| Statement |
1.Date of the board of directors resolution:
2023/08/08
2.Reason for capital reduction:
Capital reduction for restructuring of the group's
investment structure.
3.Amount of capital reduction:USD30,063,495
4.Cancelled shares:30,063,495 shares.
5.Capital reduction percentage:36.40%
6.Share capital after capital reduction:52,531,075
shares.
7.Scheduled date of the shareholders meeting:
2023/08/08
8.Estimated no.of listed common shares after issuance
of new shares upon capital reduction:Not Applicable.
9.Estimated ratio of listed common shares after issuance
of new shares upon capital reduction to outstanding
common shares:Not Applicable.
10.Please explain any countermeasures for lower
circulation in shareholding if the aforesaid
estimated no.of listed common shares upon capital
reduction does not reach 60 million and the percentage
does not reach 25%:Not Applicable.
11.The record date for capital reduction:Not Applicable.
12.Any other matters that need to be specified:
Excelsior Medical (HK) Co.,Ltd. will carry out a cash
reduction, and base on its shareholding proportion,
returning USD 19,347,728 to Excelsior Medical Co.,Ltd.
and returning USD 10,715,767 to Excelsior Healthcare
Co., Limited.”
|